Allogene Therapeutics shares owned by Wildcat Capital Management
Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Wildcat Capital Management
from 13F filings
Historical chart of Wildcat Capital Management investment in Allogene Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Allogene Therapeutics held by Wildcat Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Allogene Therapeutics by Wildcat Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $3.6M | 2.9M | 1.24 |
| 2025-06-30 | $3.1M | 2.9M | 1.07 |
| 2025-03-31 | $4.3M | 2.9M | 1.46 |
| 2024-12-31 | $6.2M | 2.9M | 2.13 |
| 2024-09-30 | $8.2M | 2.9M | 2.80 |
| 2024-06-30 | $6.8M | 2.9M | 2.33 |
| 2024-03-31 | $7.9M | 1.9M | 4.10 |
| 2023-12-31 | $6.2M | 1.9M | 3.21 |
| 2023-09-30 | $6.1M | 1.9M | 3.17 |
| 2023-06-30 | $9.5M | 1.9M | 4.97 |
| 2023-03-31 | $9.5M | 1.9M | 4.94 |
| 2022-12-31 | $13M | 2.1M | 6.29 |
| 2022-09-30 | $23M | 2.1M | 10.80 |
| 2022-06-30 | $24M | 2.1M | 11.40 |
| 2022-03-31 | $19M | 2.1M | 9.11 |
| 2021-12-31 | $26M | 1.7M | 14.92 |
| 2021-09-30 | $44M | 1.7M | 25.70 |
| 2021-06-30 | $45M | 1.7M | 26.08 |
| 2021-03-31 | $54M | 1.5M | 35.30 |
| 2020-12-31 | $38M | 1.5M | 25.24 |
| 2020-09-30 | $57M | 1.5M | 37.71 |
| 2020-06-30 | $65M | 1.5M | 42.82 |
| 2020-03-31 | $26M | 1.3M | 19.44 |
| 2019-12-31 | $31M | 1.2M | 25.98 |
| 2019-09-30 | $25M | 906k | 27.25 |
| 2019-06-30 | $14M | 532k | 26.85 |
More positions owned by Wildcat Capital Management
View all positions for Wildcat Capital Management